Microbot MedicalMBOT
Market Cap: $14.6M
About: Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
Employees: 22
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
80% more call options, than puts
Call options by funds: $9K | Put options by funds: $5K
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 33 [Q1] → 34 (+1) [Q2]
3.27% less ownership
Funds ownership: 10.06% [Q1] → 6.8% (-3.27%) [Q2]
37% less capital invested
Capital invested by funds: $1.77M [Q1] → $1.11M (-$663K) [Q2]
56% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 9
Research analyst outlook
We haven’t received any recent analyst ratings for MBOT.
Financial journalist opinion
Based on 3 articles about MBOT published over the past 30 days